| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 0.00 | ||
| Total Income | 0.05 | 94.5% | 90.2% |
| Expenditure | 0.04 | 66.5% | 50.0% |
| PBT | 0.02 | 97.9% | 96.2% |
| Net Profit | 0.01 | 97.9% | 97.2% |
| OPM | — | ||
| NPM | 25.14% | 41.56pp | 61.29pp |
| EPS | 0.01 | 97.9% | 98.8% |
Bacil Pharma Ltd Reports 66.87% Increase in Profit for Q3 2025
13 Nov 2025 · 13 Nov 2025, 07:42 pm
Summary
Bacil Pharma Ltd has reported a 66.87% increase in profit for the third quarter of 2025. The company's revenue from operations stands at 100.25 with a profit from ordinary activities after tax of 66.87. The company has a single business segment and the previous quarter figures have been regrouped/reclassified where necessary.
Key Highlights
- 1
66.87% increase in profit for Q3 2025
- 2
Revenue from operations: 100.25
- 3
Profit from ordinary activities after tax: 66.87
- 4
Single business segment
- 5
Previous quarter figures regrouped/reclassified
Management Comments
N
Not provided
The text does not provide any management comments.
Informational and educational content only. Not investment advice.